GE Healthcare and Rockwell Automation are combining their automation, IT and single-use solution expertise to build bioprocessing operations for the digital age. The two companies will help biopharmaceutical companies create flexible and scalable facilities of the future, focused on rapid response to market demands, streamlined production technologies and adaptable manufacturing environments.
GE Healthcare has also joined the Rockwell Automation PartnerNetwork Programme as an OEM Partner to help drive a distributed control system offering.
Kevin Seaver, Executive General Manager, Bioprocess Automation and Digital, GE Healthcare, said: “As GE Healthcare and the healthcare ecosystem move toward precision health, flexible and scalable solutions are critical for companies to efficiently manufacture smaller batches of tailored medicines. Our collaboration with Rockwell Automation is an integral part of our strategy to ensure we deliver innovative solutions that meet the needs of the biopharma 4.0 era.”
Fran Wlodarczyk, Senior Vice President, Architecture and Software, Rockwell Automation said: “Our collaboration with GE Healthcare will help make bioprocessing operations more agile. The facility of the future reimagines what’s possible in production of biopharmaceuticals. It uses connectivity, information, and modular equipment to create smaller-scale, more efficient operations. Our partnership will help GE Healthcare bring this possibility to life, so they can meet demands for more targeted drugs and get products to market faster.”
GE Healthcare and Rockwell Automation can help companies:
Automation improves operational efficiency with reduced production risk and streamlines workflows resulting in faster times to market.
This partnership leverages the combined expertise in single-use bioprocessing with deep automation and IT knowledge to turn data insights into productive outcomes.